Navigation Links
Basal in Medical Technology
... Malignancies reported through week 104 included basal cell skin cancer (one patient), colon cancer (one ... patient) in patients receiving SIMPONI 50 mg, and basal cell skin cancer (three patients), prostate ... reported through week 104 consisted of two basal cell skin cancers (one patient on SIMPONI 100 mg, ...
... (pramlintide acetate) injection with basal insulin therapy for 24 weeks resulted in more ... to the use of rapid-acting insulin (RAI) with basal insulin in patients with type 2 diabetes. The ... rapid-acting insulin when either was added to basal insulin treatment in this study, with SYMLIN use ...
... glargine. Patients with type 2 diabetes using basal insulin without bolus insulin (N=35) were ... blood glucose targets during a pre-specified basal period (12 p.m. to 6 a.m.). No food was eaten between 6 p.m. to ~7 a.m. in order to obtain accurate basal readings. ...
... the changes in local cerebral blood flow. Analysis of the changes in basal regional cerebral blood flow indicated a selective increase in blood flow ... considered to be significant for indications such as pain and depression. basal blood flow in other brain areas was unaffected. These findings represent ...
... cured. While melanoma is the most serious form of skin cancers, it accounts for less than 10 percent of all cases. Non-melanoma skin cancers, such as basal cell carcinoma and squamous cell carcinoma, represent the majority of all new cases. "We are dedicated to bringing the most complete and ...
... MJFF funding, they are working in a pre-clinical model of PD to assess the practical potential of modifying abnormal synchronization in the brain's basal ganglia region -- an approach that, according to preliminary theoretical studies, could result in functional improvements for PD patients. ...
... two 52-week studies show that the investigational ultra rapid acting insulin AFRESA(R) (insulin human [rDNA origin]) Inhalation Powder combined with basal insulin is comparable to standard of care therapies in controlling post-meal blood sugar levels, and also results in significantly less weight gain ...
... neural stem cells, multiply them in vitro and ultimately differentiate them to produce mature neurons before they are reintroduced into the brain's basal ganglia. This is performed without the patient requiring immunosuppressants. Of particular note are the striking results this study yielded -- for ...
... in extreme cases, a loss of physical movement (akinesia). The primary symptoms are the results of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Secondary ...
... CEO of deCODE and senior author on the paper. deCODE discovered the first variant, a SNP called rs 401681, in its gene discovery work on basal cell carcinoma (BCC), a common form of skin cancer. The SNP is in the gene encoding cisplatin resistance related protein 9 (CLPTM1L). Because the ...
... considered a gold standard for patients with late stage type 2 diabetes who have difficulty achieving glycemic targets with oral medications and/or basal insulin alone," explained study author Andreas Fritsche, MD, IVth Medical Department, University of Tübingen, Germany. When compared to pre-mixed ...
... common in the Carb Counting group than in the Simplified Algorithm group (8.0 vs. 4.9 events/patient-year, P=0.02). "A combination of basal and bolus insulin may be needed to achieve optimal glucose control in type 2 diabetes patients," explained study author Richard M. Bergenstal, MD, ...
... developed breast cancer, one patient taking golimumab 100 mg plus placebo developed Bowen's disease and one patient taking placebo plus MTX developed basal cell carcinoma. There were no reports of opportunistic infection or tuberculosis. About the GO-BEFORE Trial GO-BEFORE, a Phase 3, multi-center, ...
... Lantus(R) when Initiated Promptly in patients with type 2 diabetes) clinical study, 66 percent of patients who began treatment with the long-acting, basal insulin Lantus(R) (insulin glargine [rDNA origin] injection) achieved A1C <7%, the ADA's recommended target for glycemic control, while only 38 ...
... Cancer Research (AACR) Annual Meeting in San Diego, CA. The study, conducted in mouse models of oral mucositis, showed that NU206 regenerated basal layer epithelial cells and accelerated cell repair by stimulating the Wnt pathway, a signaling pathway that is critical for cell growth and ...
... About Apidra(R) Apidra(R) works fast and offers flexible insulin dosing to help manage mealtime blood sugar levels. Along with exercise, a basal insulin, and a proper meal plan, Apidra(R) is proven to help reduce A1C levels in adults with type 1 and type 2 diabetes. Apidra(R) can be ...
... in five percent of patients receiving golimumab and three percent of patients receiving placebo. One case of prostate cancer and two cases of basal cell carcinoma were reported in golimumab-treated patients. There were no reports of tuberculosis or opportunistic infections through week 24. About ...
... 1982. Gewirth's research is focused primarily on structural studies of HSP90 chaperones, drug design, protein folding; nuclear hormone receptors; and basal transcription factors. Gewirth and his wife live in Buffalo. About HWI With more than 50 years of exceptional scientific research, HWI is ...
... Dr. Gross at Skin Surgery Medical Group specializes in the following: skin cancer diagnosis and treatment including but not limited to melanoma, basal cell cancer, squamous cell cancer; diagnosis and treatment of moles and melanoma including sentinel node biopsy of lymph nodes; Mohs Surgery of skin ...
... segmental body composition test measures lean body mass, total body water, and percent of body fat. (2) The calorimetry determines the body's basal metabolic rate or resting energy expenditure and locates a weight management zone. (3) The patient wears a multisensor arm band 5-10 days at ...
... in the incidence of adverse events. The efficacy of ENDOMETRIN was also evaluated in harder-to-treat patients - women over age 35 or with elevated basal follicle stimulating hormone (FSH) or body mass index (BMI). Excellent continuing pregnancy rates were observed across a broad range of patient types ...
... Levemir(R), as patients were able to adjust their basal insulin dose on their own and achieve the same ... analogs like Levemir(R), which provide effective basal insulin coverage, and, as shown in this study, ... insulin to show less weight gain versus other basal insulins in 12 of 12 controlled clinical ...
... patients were able to adjust their basal insulin dose on their own and achieve the same ... like Levemir®, which provide effective basal insulin coverage, and, as shown in this study, ... insulin to show less weight gain versus other basal insulins in 12 of 12 controlled clinical trials*. ...
... Administered at Lunchtime in Juvenile Type-1 DM Subjects Maintained on basal Glargine Insulin and Pre-Breakfast and Pre-Dinner Regular Insulin, by ... Insulin (Generex Oral-lyn(tm)) In Adult Type-1 DM Subjects Maintained on basal S.C. BID Isophane Insulin (NPH), by Doctors Jaime Guevara-Aguirre, Marco ...
... in extreme cases, a loss of physical movement (akinesia). The primary symptoms are the results of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Secondary ...
FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
... be used in combination with a longer-acting or basal insulin. Apidra(R) can also be used in insulin ... insulin glargine once daily or NPH twice daily as basal insulin. The majority of the patients received ... after the start of a meal. Along with exercise, a basal insulin, and a proper meal plan, Apidra(R) is ...... (pramlintide acetate) injection with basal insulin therapy for 24 weeks resulted in more ... to the use of rapid-acting insulin (RAI) with basal insulin in patients with type 2 diabetes. The ... rapid-acting insulin when either was added to basal insulin treatment in this study, with SYMLIN use ...
... glargine. Patients with type 2 diabetes using basal insulin without bolus insulin (N=35) were ... blood glucose targets during a pre-specified basal period (12 p.m. to 6 a.m.). No food was eaten between 6 p.m. to ~7 a.m. in order to obtain accurate basal readings. ...
New Study Showed Lantus(R) Plus One, Two or Three Shots of Apidra(R) Lowered Patients' Blood Sugar
... administered before 1 meal, 2 meals or 3 meals daily, already taking basal insulin, Lantus(R) (insulin glargine [rDNA origin] injection), with or ... were not statistically significant between groups. "By combining basal insulin Lantus(R) plus Apidra(R) mealtime insulin at one, two or three ...Major State Grant Accelerates Research and Development of Novel Cancer Therapy
... in the world. The two most common types of non-melanoma skin cancers are basal cell carcinoma and squamous cell carcinoma (SCC). One in five Americans ... which are more effective in treating actinic keratosis, and potentially basal cell carcinoma and squamous cell carcinoma," said Chakoff. Florida ...deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer
... traits also associated with risk of cutaneous melanoma (CM) and basal cell carcinoma (BCC). CM is the most dangerous form of skin cancer, while ... 'ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma,' are published today in the online edition of Nature ...... the changes in local cerebral blood flow. Analysis of the changes in basal regional cerebral blood flow indicated a selective increase in blood flow ... considered to be significant for indications such as pain and depression. basal blood flow in other brain areas was unaffected. These findings represent ...
... cured. While melanoma is the most serious form of skin cancers, it accounts for less than 10 percent of all cases. Non-melanoma skin cancers, such as basal cell carcinoma and squamous cell carcinoma, represent the majority of all new cases. "We are dedicated to bringing the most complete and ...
5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH
... 5-year, randomized (1:1), multicentre, stratified, parallel-group study comparing patients treated with either twice-daily NPH (n=509) or once-daily basal glargine (n=515). The main objective of this study was to compare the progression of diabetic retinopathy between treatment groups by analyzing ...... MJFF funding, they are working in a pre-clinical model of PD to assess the practical potential of modifying abnormal synchronization in the brain's basal ganglia region -- an approach that, according to preliminary theoretical studies, could result in functional improvements for PD patients. ...
... two 52-week studies show that the investigational ultra rapid acting insulin AFRESA(R) (insulin human [rDNA origin]) Inhalation Powder combined with basal insulin is comparable to standard of care therapies in controlling post-meal blood sugar levels, and also results in significantly less weight gain ...
... neural stem cells, multiply them in vitro and ultimately differentiate them to produce mature neurons before they are reintroduced into the brain's basal ganglia. This is performed without the patient requiring immunosuppressants. Of particular note are the striking results this study yielded -- for ...
... in extreme cases, a loss of physical movement (akinesia). The primary symptoms are the results of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Secondary ...
ISTA Pharmaceuticals Announces Positive Results for Phase IIb Study of Ecabet Sodium
... strong trend for ecabet sodium, which approached statistical significance versus placebo. This result is important because it indicates an effect on basal tear secretion, which is one of the main factors in the etiology of dry eye disease. In addition, the percentage of patients who responded to ecabet ...... CEO of deCODE and senior author on the paper. deCODE discovered the first variant, a SNP called rs 401681, in its gene discovery work on basal cell carcinoma (BCC), a common form of skin cancer. The SNP is in the gene encoding cisplatin resistance related protein 9 (CLPTM1L). Because the ...
... considered a gold standard for patients with late stage type 2 diabetes who have difficulty achieving glycemic targets with oral medications and/or basal insulin alone," explained study author Andreas Fritsche, MD, IVth Medical Department, University of Tübingen, Germany. When compared to pre-mixed ...
... common in the Carb Counting group than in the Simplified Algorithm group (8.0 vs. 4.9 events/patient-year, P=0.02). "A combination of basal and bolus insulin may be needed to achieve optimal glucose control in type 2 diabetes patients," explained study author Richard M. Bergenstal, MD, ...
... developed breast cancer, one patient taking golimumab 100 mg plus placebo developed Bowen's disease and one patient taking placebo plus MTX developed basal cell carcinoma. There were no reports of opportunistic infection or tuberculosis. About the GO-BEFORE Trial GO-BEFORE, a Phase 3, multi-center, ...
DURABLE Clinical Trial Results Show GlycoMark is Key Test for Managing Patients with Diabetes
... of GlycoMark to reflect after-meal glucose levels with 2,094 patients enrolled from 11 countries. The DURABLE trial (Assessing the Durability of basal vs. Lispro Mix 75/25 Insulin Efficacy) confirms results from a smaller population study completed by John Buse, MD (University of North ...... Lantus(R) when Initiated Promptly in patients with type 2 diabetes) clinical study, 66 percent of patients who began treatment with the long-acting, basal insulin Lantus(R) (insulin glargine [rDNA origin] injection) achieved A1C <7%, the ADA's recommended target for glycemic control, while only 38 ...
... Cancer Research (AACR) Annual Meeting in San Diego, CA. The study, conducted in mouse models of oral mucositis, showed that NU206 regenerated basal layer epithelial cells and accelerated cell repair by stimulating the Wnt pathway, a signaling pathway that is critical for cell growth and ...
... About Apidra(R) Apidra(R) works fast and offers flexible insulin dosing to help manage mealtime blood sugar levels. Along with exercise, a basal insulin, and a proper meal plan, Apidra(R) is proven to help reduce A1C levels in adults with type 1 and type 2 diabetes. Apidra(R) can be ...
... in five percent of patients receiving golimumab and three percent of patients receiving placebo. One case of prostate cancer and two cases of basal cell carcinoma were reported in golimumab-treated patients. There were no reports of tuberculosis or opportunistic infections through week 24. About ...
... 1982. Gewirth's research is focused primarily on structural studies of HSP90 chaperones, drug design, protein folding; nuclear hormone receptors; and basal transcription factors. Gewirth and his wife live in Buffalo. About HWI With more than 50 years of exceptional scientific research, HWI is ...
... Dr. Gross at Skin Surgery Medical Group specializes in the following: skin cancer diagnosis and treatment including but not limited to melanoma, basal cell cancer, squamous cell cancer; diagnosis and treatment of moles and melanoma including sentinel node biopsy of lymph nodes; Mohs Surgery of skin ...
... segmental body composition test measures lean body mass, total body water, and percent of body fat. (2) The calorimetry determines the body's basal metabolic rate or resting energy expenditure and locates a weight management zone. (3) The patient wears a multisensor arm band 5-10 days at ...
... in the incidence of adverse events. The efficacy of ENDOMETRIN was also evaluated in harder-to-treat patients - women over age 35 or with elevated basal follicle stimulating hormone (FSH) or body mass index (BMI). Excellent continuing pregnancy rates were observed across a broad range of patient types ...
New Data Confirm That Use of Levemir Can Limit Weight Gain
... published where it has been compared to other basal insulins.(10-23) Collectively these trials ... (insulin analogue) that covers the body’s basal insulin needs. Levemir® is released gradually ... NPH insulin in patients with type 1 diabetes on a basal bolus regimen with premeal insulin aspart. ...... Levemir(R), as patients were able to adjust their basal insulin dose on their own and achieve the same ... analogs like Levemir(R), which provide effective basal insulin coverage, and, as shown in this study, ... insulin to show less weight gain versus other basal insulins in 12 of 12 controlled clinical ...
... patients were able to adjust their basal insulin dose on their own and achieve the same ... like Levemir®, which provide effective basal insulin coverage, and, as shown in this study, ... insulin to show less weight gain versus other basal insulins in 12 of 12 controlled clinical trials*. ...
... Administered at Lunchtime in Juvenile Type-1 DM Subjects Maintained on basal Glargine Insulin and Pre-Breakfast and Pre-Dinner Regular Insulin, by ... Insulin (Generex Oral-lyn(tm)) In Adult Type-1 DM Subjects Maintained on basal S.C. BID Isophane Insulin (NPH), by Doctors Jaime Guevara-Aguirre, Marco ...
AVEO Pharmaceuticals Novel Oncology Research Platform and Clinical Pipeline to Be Featured at AACR
... (p110alpha)" - Poster Session: Mouse Models of Cancer - Section 21, Board 4 -- Tuesday, April 17, 2007 at 8:00 a.m. to 12:00 p.m. "Novel human basal type breast cancer models generated through genetic manipulation of normal human breast tissue in mice" - Poster Session: Mouse Models of Cancer - ...Ferring Reports on ENDOMETRIN Presentations at Pacific Coast Reproductive Society Annual Meeting
... Results in Harder-to-Treat Patients The activity of ENDOMETRIN was also evaluated in harder-to-treat patients - women over age 35, or with elevated basal follicle stimulating hormone (FSH) or body mass index (BMI). Excellent continuing pregnancy rates were observed across a broad range of patient types ...... in extreme cases, a loss of physical movement (akinesia). The primary symptoms are the results of decreased stimulation of the motor cortex by the basal ganglia, normally caused by the insufficient formation and action of dopamine, which is produced in the dopaminergic neurons of the brain. Secondary ...
Solstice Neurosciences Presents Escalating Dose Study at International Congress in Istanbul, Turkey
... dystonia requiring referral to movement disorder clinics. While the exact cause of CD is unknown, scientists believe the problem originates in the basal ganglia area of the brain that is instrumental in movement. In general, there are three main approaches to the treatment of CD: oral medications, ...Amylin Pharmaceuticals to Present New Data from Broad Diabetes and Obesity Programs at ADA 2007
... PM ET). 4. Poster: "Pramlintide Improved Glycemic Control without Increased Risk of Hypoglycemia in Patients with Type 2 Diabetes Using basal Insulin" will be presented by Karen Lutz, Ph.D. during a poster session on Sunday, June 24 at 12:00 PM CT (1:00 PM ET). 5. ...Other ContentsOther TagsOther Tags
(Date:5/24/2013)... the search for medication against Alzheimer,s disease, scientists have focused ... down Amyloid beta (A-beta). After all, it is the accumulation ... of Alzheimer,s patients. Starting point for the formation of A-beta ... the first to unravel the function of APPL the ... fruit flies. , Alessia Soldano (VIB/KU Leuven): "We have ...
(Date:5/23/2013)... RICHLAND, Wash. Pacific Northwest National Laboratory honored ... and commercialization of intellectual property at PNNL,s annual ... , The Department of Energy national laboratory ... Year for his work developing battery materials that ... to the electrical grid, and reduce the time ...
(Date:5/23/2013)... genomic DNA around nucleosomes in the cell nucleus ... of Ludwig-Maximilians-Universitaet (LMU) in Munich now describes a ... displaced from nucleosomes for transcription. , In higher ... cell nucleus, wrapped around disk-shaped particles called nucleosomes, ... histone proteins and accommodating two loops of DNA. ...
Breaking Biology News(10 mins):A new strategy required in the search for Alzheimer's drugs? 2PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2Biochemistry: Unspooling DNA from nucleosomal disks 2(Date:5/25/2013)... May 25, 2013 HealthCrave Medical ... is unique in that it doesn’t just focus ... on treating what causes the noticeable signs of ... Dr. James D. Weiss, M.D., the center provides ... process while helping patients to live longer, healthier ...
(Date:5/24/2013)... A recent study by research group Harris ... upcoming bathing suit season. Almost 138 million people are fearful ... due to weight issues and a quarter admit they feel ... Labs recommends that those anxious about their size consider the ... of an overall effort to improve diet and exercise habits ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Compromise is often ... compromise when it comes to sleep and comfort. However, many ... prove highly individual. For some, this can cause added stress, ... mattress advice blog, tackles eight common issues in their latest ... Wants Soft, He Wants Firm: What to do When You ...
(Date:5/24/2013)... York (PRWEB) May 24, 2013 ... DePuy hip recall continue to move forward in courts ... to documents filed in California’s San Francisco Superior Court ... an expedited trial of her DePuy hip lawsuit is ... DePuy Orthopaedics, Inc., et al., No. CGC11508806; Calif. Super. ...
(Date:5/24/2013)... KC and Monica Craichy, Founders of Living ... oldest sons, Kyle and Austin Craichy, will be kiteboarding with ... professional kiteboarders. , KC Craichy said he is excited to ... together such that virtually everyone who planned to be involved ... boarders will meet at Matheson Hammock Park and Beach in ...
Breaking Medicine News(10 mins):Health News:Anti-Aging Center Offers Advanced Treatment that Controls the Aging Process from Within 2Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 2Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 3Health News:What’s The Best Bed Offers Mattress & Sleep Solutions for Opposite Couples 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 2Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 3Health News:DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case 4Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 2Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 3[0] Anti-Aging Center Offers Advanced Treatment that Controls the Aging Process from Within[0] PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful[0] What’s The Best Bed Offers Mattress & Sleep Solutions for Opposite Couples[0] DePuy ASR Hip Lawsuit News: Bernstein Liebhard LLP Notes Request for Voluntary Dismissal in California DePuy Hip Recall Case[0] FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |